It has been estimated that between 40% and 60% of patients with PD use at least one form of complementary medicine. In this podcast, neurologist Sarah Mulukutla, MD, MPH talks about CAM options for neurologists to discuss with their patients.
Podcasts
The importance of effective communication and cultural awareness in patient care and outcomes cannot be overstated.
Dr. Abhinav Raina presents his research on the effect of subthalamic nucleus deep brain stimulation on impulsivity in Parkinson disease patients.
An expert presents the results of a phase 2 study on the impact of rituximab on myasthenia gravis.
An expert describes the efficacy of fenfluramine in decreasing seizure frequency associated with this rare syndrome.
A unique case of chronic, low level carbon monoxide poisoning in a car mechanic that resulted in Parkinsonian symptoms.
What does epigenetics have to do with risk for Alzheimer disease? Are our epigenetics immutable? What are the therapeutic implications? Those questions answered in this podcast.
What medications are in the pipeline that may help slow or even prevent the development of Alzheimer disease?
An expert discusses the latest guidelines to reduce brain injury in adults who are comatose after cardiac resuscitation.
Key details about an option for the treatment of drug-resistant epilepsy in patients who are not surgical candidates.
Alzheimer disease is not an equal opportunity employer. Insights about early life stressors and economic disadvantage.
What do the new AAN guidelines on SUDEP offer? Here’s a quick overview of the key facts.
The largest study of its kind shows that 8 in 1000 people have epilepsy--a distinctly higher incidence than previously thought. Details and implications in this podcast.
In this podcast, Ann Scher, PhD, lead author in a recently published study, gives a succinct overview of the details and briefly discusses what the findings may suggest.
Persons with epilepsy have a higher prevalence of comorbid conditions-psychiatric disorders in particular-than the general population.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Alzheimer Trial PRImus-AD Tests Orally Available PRI-002 as New Treatment
2
Alzheimer Vaccine ABvac40 Results in Lowered Cortical Perfusion Decline
3
New Clarity AD Analysis Reveal How Lecanemab Engages and Clears Neurotoxic Protofibrils in Alzheimer Disease
4
Phase 3 Trial to Uncover Therapeutic Potential of 5-HT6 Antagonist Masupirdine to Treat Alzheimer Agitation
5
